Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.

Literature DB >> 8088076

Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.

Abstract

More than half the patients with temporal arteritis experience steroid-related side effects, which are associated with increased morbidity and may shorten life expectancy. We describe 3 such patients, and our experience in tapering their steroid dosage with the use of dapsone or methotrexate. Based on our data and the review of 174 reported patients, it seems that no definite recommendation can be drawn regarding the use of steroid-sparing agents in temporal arteritis. There is a need for large controlled studies of several potential agents to evaluate their role in the treatment of this disease.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1994 PMID： 8088076 DOI： 10.1007/bf02249029

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

12 in total

1. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.

Authors: E Nordborg; B A Bengtsson
Journal: BMJ Date: 1989-08-26

2. Dapsone in temporal arteritis and polymyalgia rheumatica.

Authors: P Boesen; K Dideriksen; J Stentoft; M K Jensen
Journal: J Rheumatol Date: 1988 Impact factor: 4.666

3. Long-term treatment of temporal arteritis with dapsone.

Authors: E Reinitz; A Aversa
Journal: Am J Med Date: 1988-09 Impact factor: 4.965

4. Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids.

Authors: A Rubinow; K D Brandt; A S Cohen; B Sack
Journal: Ann Ophthalmol Date: 1984-03

5. The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica.

Authors: P Doury; S Pattin; F Eulry; A Thabaut
Journal: Arthritis Rheum Date: 1983-05

6. [Results of a regional survey on the treatment of rhizomelic pseudopolyarthritis and temporal arteritis. Apropos of 242 cases treated by various modalities with synthetic antimalarials, corticoids and non-steroidal anti-inflammatory agents].

Authors: J David-Chaussé; J Dehais; A Leman
Journal: Rev Rhum Mal Osteoartic Date: 1983 Jul-Sep

7. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.

Authors: M De Silva; B L Hazleman
Journal: Ann Rheum Dis Date: 1986-02 Impact factor: 19.103

8. [Disulon in the treatment of Horton's disease. Experience with 20 patients].

Authors: F Liozon; E Vidal; J M Bonnetblanc; J P Michel; P Weinbreck; D Bordessoule; V Loustaud
Journal: Ann Med Interne (Paris) Date: 1986

9. Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.

Authors: P L Krall; D J Mazanec; W S Wilke
Journal: Cleve Clin J Med Date: 1989-05 Impact factor: 2.321

10. Prognosis in giant-cell arteritis.

Authors: E Graham; A Holland; A Avery; R W Russell
Journal: Br Med J (Clin Res Ed) Date: 1981-01-24

6 in total

Review 1. Giant cell arteritis.

Authors: J M Calvo-Romero
Journal: Postgrad Med J Date: 2003-09 Impact factor: 2.401

5. The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).

Authors: Jurij R Bilyk; Ann P Murchison; Benjamin T Leiby; Robert C Sergott; Ralph C Eagle; Laurence Needleman; Peter J Savino
Journal: Trans Am Ophthalmol Soc Date: 2018-06-25

Review 6. [Methotrexate therapy in rheumatologic diseases--an update].

Authors: Edmund Cauza; Attila Dunky
Journal: Wien Med Wochenschr Date: 2003